Submitted by Anonymous (not verified) on 24 June 2025 - 17:26
Opinion/decision on a Paediatric investigation plan (PIP): Constella, linaclotide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0529/2022
Source: